SEMAGLUTIDE IMPROVES LIVER ENZYMES AND FATTY LIVER INDEX IN PATIENTS WITH OBESITY AND CARDIOVASCULAR DISEASE - RESULTS FROM THE SELECT TRIAL

被引：0
|
作者：
Meyhoefer, Sebastian [1 ]
Cariou, Bertrand [2 ]
Cercato, Cintia [3 ]
Colhoun, Helen [4 ]
Deanfield, John [5 ]
Kjaer, Mette Skalshoi [6 ]
Jeppesen, Ole [6 ]
Lincoff, A. Michael [7 ,8 ]
Lingvay, Ildiko [9 ]
Newsome, Phillip [10 ,11 ]
Nicholls, Stephen [12 ]
Pelaez, Maria De Los Angeles Quiroga [6 ]
Santini, Ferruccio [13 ]
Sanyal, Arun [14 ]
Kahn, Steven [15 ,16 ]
机构：
[1] Novo Nordisk Pharma GmbH, Clin Med & Regulatory, Mainz, Germany
[2] Nantes Univ, CHU Nantes, CNRS, INSERM,Inst Thorax, Nantes, France
[3] Univ Sao Paulo, Hosp Clin, Dept Endocrinol, Obes Unit, Sao Paulo, Brazil
[4] Univ Edinburgh, Inst Genet & Canc, Edinburgh, Midlothian, Scotland
[5] UCL, Inst Cardiovasc Sci, London, England
[6] Novo Nordisk AS, Soborg, Denmark
[7] Cleveland Clin, Cleveland, OH 44106 USA
[8] Case Western Reserve Univ, Lerner Coll Med, Cleveland, OH 44106 USA
[9] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
[10] Kings Coll London, Inst Hepatol, London, England
[11] Kings Coll Hosp London, London, England
[12] Monash Univ, Victorian Heart Inst, Melbourne, Vic, Australia
[13] Univ Hosp Pisa, Obes & Lipodystrophy Ctr, Pisa, Italy
[14] Virginia Commonwealth Univ, Sch Med, Richmond, VA USA
[15] VA Puget Sound Hlth Care Syst, Seattle, WA USA
[16] Univ Washington, Seattle, WA 98195 USA
来源：
HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
623
引用
收藏
页码：S457 / S459
页数：3
相关论文
共 50 条
  • [21] Fatty Liver Index and Development of Cardiovascular Disease: Findings from the UK Biobank
    Zou, Biyao
    Yeo, Yee Hui
    Cheung, Ramsey
    Ingelsson, Erik
    Nguyen, Mindie H.
    DIGESTIVE DISEASES AND SCIENCES, 2021, 66 (06) : 2092 - 2100
  • [22] Fatty Liver Index and Development of Cardiovascular Disease: Findings from the UK Biobank
    Biyao Zou
    Yee Hui Yeo
    Ramsey Cheung
    Erik Ingelsson
    Mindie H. Nguyen
    Digestive Diseases and Sciences, 2021, 66 : 2092 - 2100
  • [23] Alcoholic liver disease/nonalcoholic fatty liver disease index: distinguishing alcoholic from nonalcoholic fatty liver disease
    Cerovic, Ivana
    Mladenovic, Dusan
    Jesic, Rada
    Naumovic, Tamara
    Brankovic, Milos
    Vucevic, Danijela
    Aleksic, Vuk
    Radosavljevic, Tatjana
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2013, 25 (08) : 899 - 904
  • [24] Alcoholic Liver Disease/Nonalcoholic Fatty Liver Disease Index for Classification of Patients with Steatotic Liver Disease
    Roy, Akash
    De, Arka
    Kulkarni, Anand V.
    Jajodia, Surabhi
    Goenka, Usha
    Tewari, Awanish
    Sonthalia, Nikhil
    Goenka, Mahesh K.
    JOURNAL OF OBESITY & METABOLIC SYNDROME, 2024, 33 (03) : 222 - 228
  • [25] The effect of semaglutide on liver enzymes in subjects with obesity and elevated alanine aminotransferase: data from a randomised phase 2 trial
    Monk-Hansen, T.
    Van Gaal, L.
    Harrison, S.
    Rasmussen, S.
    Newsome, P. N.
    DIABETOLOGIA, 2018, 61 : S589 - S589
  • [26] The effect of semaglutide on liver enzymes in subjects with obesity and elevated alanine aminotransferase: Data from a randomised Phase 2 trial
    Newsome, P.
    Harrison, S.
    Rasmussen, Soren
    Hansen, T. M.
    Gaal, L. V.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S581 - S581
  • [27] The Effect of Semaglutide on Liver Enzymes in Subjects with Obesity and Elevated Alanine Aminotransferase: Data from a Randomized Phase 2 Trial
    Newsome, Philip N.
    Harrison, Stephen A.
    Rasmussen, Soren
    Fries, Tea Monk
    Van Gaal, Luc
    HEPATOLOGY, 2018, 68 : 67A - 67A
  • [28] Fatty Liver Disease in Patients with Prediabetes and Overweight or Obesity
    Arias-Fernandez, Maria
    Fresneda, Sergio
    Abbate, Manuela
    Torres-Carballo, Marina
    Huguet-Torres, Aina
    Sanchez-Rodriguez, Cristian
    Bennasar-Veny, Miquel
    Yanez, Aina M.
    Busquets-Cortes, Carla
    METABOLITES, 2023, 13 (04)
  • [29] Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
    Targher, Giovanni
    Day, Christopher P.
    Bonora, Enzo
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (14): : 1341 - 1350
  • [30] CARDIOVASCULAR RISK IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE
    Ceasovschih, A.
    Sorodoc, V.
    Lionte, C.
    Statescu, C.
    Sascau, R. A.
    Aursulesei, V. Onofrei
    Haliga, R. E.
    Bologa, C.
    Stoica, A.
    Sirbu, O.
    Coman, A. E.
    Grigorescu, E. -D.
    Petris, O. R.
    Pavel, M.
    Constantin, M.
    Diaconu, A. -D.
    Morarasu, B. C.
    Rusu-Zota, G.
    Profire, B.
    Culis, N.
    Clim, A.
    Sorodoc, L.
    ATHEROSCLEROSIS, 2023, 379 : S82 - S83
12345